PubMed:32829416 22 Projects
The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.
|
Annnotations
- Denotations: 0
- Blocks: 0
- Relations: 0
The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.
|